Molecular analysis of the dystrophin gene in 407 Chinese patients with Duchenne/Becker muscular dystrophy by the combination of multiplex ligation-dependent probe amplification and Sanger sequencing
Authors:
- 13 April 2013
- journal article
- Published by Elsevier in Clinica Chimica Acta
- Vol. 423, 35-38
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- Diagnosis and management of Duchenne muscular dystrophy, part 1: diagnosis, and pharmacological and psychosocial managementThe Lancet Neurology, 2010
- Local restoration of dystrophin expression with the morpholino oligomer AVI-4658 in Duchenne muscular dystrophy: a single-blind, placebo-controlled, dose-escalation, proof-of-concept studyThe Lancet Neurology, 2009
- Genotype-phenotype analysis in 2,405 patients with a dystrophinopathy using the UMD-DMD database: a model of nationwide knowledgebaseHuman Mutation, 2009
- Integrated DNA, cDNA, and protein studies in Becker muscular dystrophy show high exception to the reading frame ruleHuman Mutation, 2008
- Molecular deletion patterns in Duchenne and Becker muscular dystrophy patients from KwaZulu NatalJournal of the Neurological Sciences, 2007
- Intronic breakpoint definition and transcription analysis in DMD/BMD patients with deletion/duplication at the 5′ mutation hot spot of the dystrophin geneGene, 2006
- Relative quantification of 40 nucleic acid sequences by multiplex ligation-dependent probe amplificationNucleic Acids Research, 2002
- Late diagnosis of Duchenne's muscular dystrophy presenting as global developmental delayBMJ, 2001
- 6 Dystrophin, Its Gene, and the DystrophinopathiesAdvances in Genetics, 1995
- The clinical, genetic and dystrophin characteristics of Becker muscular dystrophyJournal of Neurology, 1993